Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells.

Cancer research and treatment·2025

Same author

Sickle Cell Disease Related Vasculopathies and Early Evaluation in a Pediatric Population.

In vivo (Athens, Greece)·2024

Same author

Chronic Myeloid Leukemia in Children and Adolescents.

Advances in pediatrics·2023

Same author

Publisher Correction to: Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma.

Pediatric research·2023

Same author

Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma.

Pediatric research·2023

Same author

Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy.

In vivo (Athens, Greece)·2022

Search research articles

Related Experiment Video

Updated: Jun 22, 2025

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Pediatric Immune Thrombocytopenia.

Moran Gotesman¹, Marni Shear², Sahar Raheel²

¹The Lundquist Institute of Biomedical Innovation, Torrance, CA, USA; Department of Pediatrics, Harbor UCLA Medical Center, 1000 W Carson Street, Box 468, Torrance, CA 90509, USA.

Advances in Pediatrics

|June 29, 2024

Summary

Pediatric immune thrombocytopenia (ITP) is a common bleeding disorder characterized by low platelets. While many cases resolve spontaneously, treatments like steroids or IVIg are available for persistent conditions.

Keywords:

Acute/chronic Bleeding ITP Immune thrombocytopenia Petechiae

More Related Videos

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Related Experiment Videos

Last Updated: Jun 22, 2025

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Area of Science:

Hematology
Immunology
Pediatrics

Background:

Pediatric immune thrombocytopenia (ITP) is a prevalent bleeding disorder.
It is characterized by a reduced platelet count, leading to symptoms like bruising and petechiae.
ITP is primarily considered an autoimmune disorder, with other contributing mechanisms recently identified.

Purpose of the Study:

To provide an overview of pediatric immune thrombocytopenia (ITP).
To discuss the typical presentation, diagnostic considerations, and management strategies for ITP in children.
To highlight the potential for new therapeutic agents in future pediatric clinical trials.

Main Methods:

Review of current understanding of ITP pathophysiology.
Description of common clinical manifestations and diagnostic approaches.
Summary of established and emerging treatment options for pediatric ITP.

Main Results:

Most pediatric ITP cases exhibit mild bleeding symptoms.
Spontaneous resolution is common, often managed with watchful waiting.
Initial treatments may include steroids or intravenous immunoglobulin G (IVIg).

Conclusions:

Pediatric ITP often resolves spontaneously with conservative management.
Steroids and IVIg are standard initial therapies.
Persistent ITP requires ongoing management, with future therapeutic advancements anticipated.